Support The World's Smartest Network
×

Help the New York Academy of Sciences bring late-breaking scientific information about the COVID-19 pandemic to global audiences. Please make a tax-deductible gift today.

DONATE
This site uses cookies.
Learn more.

×

This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

We encourage you to learn more about cookies on our site in our Privacy policy and Terms of Use.

New Therapeutic Strategies to Combat Antibacterial Resistance

Available via

WEBINAR

New Therapeutic Strategies to Combat Antibacterial Resistance

Tuesday, October 23, 2018, 9:00 AM - 6:00 PM EDT

The New York Academy of Sciences, 7 World Trade Center, 250 Greenwich St Fl 40, New York

Presented By

The New York Academy of Sciences

The Biochemical Pharmacology Discussion Group

 

Antibiotics are cornerstones of modern medicine, essential for treating patients across the spectrum of disease from routine skin infections to surgical procedures to protection for vulnerable patients receiving chemotherapy. The rise of multidrug resistance at an alarming rate constitutes a major threat to human health. According to the Centers for Disease Control and Prevention, each year in the U.S. alone, at least 2 million people become infected with bacteria that are resistant to antibiotics and 23,000 people die annually as a direct result of these infections. This symposium will focus on the current challenges that basic and translational researchers are facing to fight antimicrobial resistance, as well as offering perspectives on emerging therapeutic strategies to address this global health threat.

Registration

Member
$60
Nonmember Academia, Faculty, etc.
$105
Nonmember Corporate, Other
$160
Nonmember Not for Profit
$105
Nonmember Student, Undergrad, Grad, Fellow
$70
Member Student, Post-Doc, Fellow
$25
Member
$30
Nonmember Academia, Faculty, etc.
$65
Nonmember Corporate, Other
$85
Nonmember Not for Profit
$65
Nonmember Student, Undergrad, Grad, Fellow
$45
Member Student, Post-Doc, Fellow
$15
Deadline:
0
days
left

Scientific Organizing Committee

Eric Brown, PhD,  McMaster University
Eric Brown, PhD,
McMaster University
Junjun Gao, PhD,  Boehringer Ingelheim
Junjun Gao, PhD,
Boehringer Ingelheim
John Hambor, PhD,  Boehringer Ingelheim
John Hambor, PhD,
Boehringer Ingelheim
Deborah Hung, MD, PhD,   Broad Institute of MIT and Harvard
Deborah Hung, MD, PhD,
Broad Institute of MIT and Harvard
Eric Pamer, MD,  Memorial Sloan Kettering Cancer Center
Eric Pamer, MD,
Memorial Sloan Kettering Cancer Center
Sara Donnelly, PhD,  The New York Academy of Sciences
Sara Donnelly, PhD,
The New York Academy of Sciences
Sonya Dougal, PhD,  The New York Academy of Sciences
Sonya Dougal, PhD,
The New York Academy of Sciences

Keynote Speaker

Helen W. Boucher, MD,  Tufts University School of Medicine
Helen W. Boucher, MD,
Tufts University School of Medicine

Speakers

Eric Brown, PhD, McMaster University
Eric Brown, PhD,
McMaster University
Lynette Cegelski, PhD,  Stanford University
Lynette Cegelski, PhD,
Stanford University
Paul J Hergenrother, PhD,  University of Illinois
Paul J Hergenrother, PhD,
University of Illinois
Deborah Hung, MD, PhD,  Broad Institute of MIT and Harvard
Deborah Hung, MD, PhD,
Broad Institute of MIT and Harvard
Eric Pamer, MD,  Memorial Sloan Kettering Cancer Center
Eric Pamer, MD,
Memorial Sloan Kettering Cancer Center
Victor Nizet, MD, University of California San Diego
Victor Nizet, MD,
University of California San Diego
Richard P. Novick, MD  NYU School of Medicine
Richard P. Novick, MD
NYU School of Medicine
Elizabeth Sockett, PhD,  University of Nottingham
Elizabeth Sockett, PhD,
University of Nottingham
Helen I. Zgurskaya, PhD,  University of Oklahoma
Helen I. Zgurskaya, PhD,
University of Oklahoma

**not participating in webinar





Tuesday

October 23, 2018

8:30 AM

Registration and Breakfast

9:00 AM

Introduction and Welcome Remarks

Speakers

Marie Samanovic-Golden, PhD
The New York Academy of Sciences
Eric Pamer, MD
Memorial Sloan Kettering Cancer Center
9:15 AM

Keynote Address: Clinical Perspective on the Future of the Antibacterial Resistance Landscape

Speaker

Helen W. Boucher, MD
Tufts University School of Medicine

Session 1: Leveraging Existing Therapies against New Targets

Session Chairperson
Eric Pamer, MD, Memorial Sloan Kettering Cancer Center
10:00 AM

Bacterial Chemical Genomics: A Path of Ceased Resistance

Speaker

Eric Brown, PhD
McMaster University
10:30 AM

Networking Coffee Break

11:00 AM

Predictive Guidelines for Compound Accumulation Lead to New Broad-Spectrum Antibiotics

Speaker

Paul J Hergenrother, PhD
University of Illinois
11:30 AM

Kinetic and Molecular Determinants of Antibiotic Permeation Barriers

Speaker

Helen I. Zgurskaya, PhD
University of Oklahoma
12:00 PM

Networking Lunch and Poster Viewing

Session 2: Innovative Approaches to Develop Novel Therapies

Session Chairperson
Junjun Gao, PhD, Boehringer Ingelheim
1:00 PM

Predatory Bdellovibrio: Opportunities and Challenges as Anti-Pathogen Agents

Speaker

Elizabeth Sockett, PhD
University of Nottingham
1:30 PM

Conversion of Staphylococcal Pathogenicity Islands to CRISPR-Cas9-Based Antibacterial Drones

Speaker

Richard P. Novick, MD
NYU School of Medicine
2:00 PM

Systems Chemical Biology Approach to Antibiotic Discovery

Speaker

Deborah Hung, MD, PhD
Broad Institute of MIT and Harvard Medical School
2:30 PM

Networking Coffee Break

Speaker

Session 3: Exploiting Host-Pathogen Interactions to Develop New Therapeutics

Session Chairperson
Deborah Hung, MD, PhD, Broad Institute of MIT and Harvard
3:00 PM

New Chemistry at the Bacterial Cell Surface: Targeting Virulence and Host-Pathogen Interactions

Speaker

Lynette Cegelski, PhD
Stanford University
3:30 PM

Repurposing FDA-Approved Drugs to Sensitize MDR Pathogens to Innate Immune Clearance

Speaker

Victor Nizet, MD
University of California, San Diego
4:00 PM

Microbiota-Mediated Defense against Intestinal Infection

Speaker

Eric Pamer, MD
Memorial Sloan Kettering Cancer Center
4:30 PM

Closing Remarks

Speaker

Deborah Hung, MD, PhD
Massachusetts Institute of Technology; Harvard Medical School
4:35 PM

Networking Reception and Poster Session

5:30 PM

F1000 Poster Prize Presentation

5:35 PM

Adjourn